Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01508455 · ClinicalTrials.gov registry record · Phase 2
Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age
A Phase 2 study of Anesthesia, sponsored by Hospira, now a wholly owned subsidiary of Pfizer.
- Completed
- Registry status
- Phase 2
- Development phase
- 6
- Enrollment target
- 4
- Study locations
NCT01508455 is a Phase 2 study of Anesthesia that has completed, run by Hospira, now a wholly owned subsidiary of Pfizer. The registered enrollment target is 6 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 4 states.
The verdict
NCT01508455, a Phase 2 study of Anesthesia, has completed, sponsored by Hospira, now a wholly owned subsidiary of Pfizer.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 6 participants
- Enrollment target
- 4
- Study locations
Study Summary
The primary objective of this study is to characterize the safety, and efficacy of Dexmedetomidine (DEX) administered as an intravenous (IV) loading dose followed by a continuous IV infusion in preterm subjects, ages ≥ 28 weeks through \< 36 weeks gestational age.
Conditions Studied
Interventions
- DRUG Midazolam
- DRUG Dexmedetomidine
- DRUG Morphine
- DRUG Fentanyl
Study Locations (4)
Kentucky
- - Louisville
Pennsylvania
- - Pittsburgh
South Carolina
- - Greenville
West Virginia
- - Morgantown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01508455
The ClinicalTrials.gov registry entry for NCT01508455 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is Hospira, now a wholly owned subsidiary of Pfizer, which has 15 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Anesthesia appearing as the primary indexed condition, and to 4 interventions - of which Midazolam is the first listed.
NCT01508455 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Kentucky, Pennsylvania, South Carolina.
Frequently Asked Questions
What is clinical trial NCT01508455 about?
NCT01508455 is a clinical study titled "Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to <36 Weeks Gestational Age". The primary objective of this study is to characterize the safety, and efficacy of Dexmedetomidine (DEX) administered as an intravenous (IV) loading dose followed by a continuous IV infusion in preterm subjects, ages ≥ 28 weeks through \< 36 weeks gestational age.
What is the current status of trial NCT01508455?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 6 participants. The study started on 2012-03. Estimated completion is 2012-05.
What conditions does trial NCT01508455 study?
This clinical trial studies the following conditions: Anesthesia.
What interventions are being tested in trial NCT01508455?
The interventions under investigation include: Midazolam (DRUG), Dexmedetomidine (DRUG), Morphine (DRUG), Fentanyl (DRUG).
Who is sponsoring clinical trial NCT01508455?
This trial is sponsored by Hospira, now a wholly owned subsidiary of Pfizer, which has 15 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01508455 being conducted?
This trial has 4 study locations across Kentucky, Pennsylvania, South Carolina, West Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anesthesia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Dose-Ranging Study of Intranasal Kovacaine Mist in Pediatric Subjects
COMPLETED · Phase 2
-
Dose-Escalation Safety and Pharmacokinetic Study of K305
COMPLETED · Phase 2
-
EEG Studies of Ketamine General Anesthesia
COMPLETED · Phase 2
-
Investigating Near-Threshold Perception During Anesthetic Sedation
COMPLETED · Phase 2
-
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
RECRUITING
-
Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.